Estabrook Capital Management’s Allergan plc AGN.PRA Stock Holding History

Estabrook Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-164	Closed	-$96.1K	–	378
2017 Q4	$96.1K	Sell	164 -1,000	-86%	-$645K	0.01%	180
2017 Q3	$859K	Hold	1,164	–	–	0.13%	81
2017 Q2	$1.01M	Hold	1,164	–	–	0.16%	80
2017 Q1	$988K	Hold	1,164	–	–	0.15%	80
2016 Q4	$888K	Buy	1,164 +32	+3%	+$24.2K	0.14%	81
2016 Q3	$930K	Buy	+1,132	New	+$978K	0.14%	82

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Estabrook Capital Management's AGN.PRA Position: Q1 2018 in Review

Estabrook Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 164 shares — an estimated $96.1K sold.

Estabrook Capital Management first reported a position in AGN.PRA in Q3 2016 and held it in 6 quarters. The position peaked at $1.01M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Estabrook Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Estabrook Capital Management sold 164 Allergan plc shares in Q1 2018, an estimated $96.1K.
Estabrook Capital Management first reported a position in Allergan plc in Q3 2016 and held it in 6 quarters.
Estabrook Capital Management's Allergan plc position peaked at $1.01M in Q2 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Estabrook Capital Management's 13F filing for Q1 2018, filed 14 May 2018.